VanEck Associates’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56K Sell
2,918
-512
-15% -$11.1K ﹤0.01% 1332
2025
Q4
$75K Buy
3,430
+1,381
+67% +$24.9K ﹤0.01% 1336
2025
Q3
$25K Sell
2,049
-4,492
-69% -$60.8K ﹤0.01% 1364
2025
Q2
$122K Sell
6,541
-857
-12% -$17K ﹤0.01% 1291
2025
Q1
$142K Buy
7,398
+2,497
+51% +$73.1K ﹤0.01% 1253
2024
Q4
$177K Buy
4,901
+1,074
+28% +$36.3K ﹤0.01% 1239
2024
Q3
$123K Sell
3,827
-324
-8% -$13.7K ﹤0.01% 1242
2024
Q2
$167K Sell
4,151
-1,947
-32% -$81.2K ﹤0.01% 1204
2024
Q1
$216K Buy
6,098
+198
+3% +$5.3K ﹤0.01% 1169
2023
Q4
$175K Buy
5,900
+467
+9% +$9.69K ﹤0.01% 1179
2023
Q3
$113K Buy
5,433
+280
+5% +$7.69K ﹤0.01% 1218
2023
Q2
$126K Buy
5,153
+1,069
+26% +$34.4K ﹤0.01% 1212
2023
Q1
$166K Sell
4,084
-113
-3% -$4.68K ﹤0.01% 1192
2022
Q4
$189K Buy
4,197
+3,366
+405% +$152K ﹤0.01% 1112
2022
Q3
$40K Buy
+831
New +$45.6K ﹤0.01% 1279

Other funds holding TNDM